Salarius Pharmaceuticals Inc (SLRX) Social Stream

Salarius Pharmaceuticals Inc (SLRX): $0.20

-0.02 (-9.12%)

POWR Rating

Component Grades













Salarius Pharmaceuticals Inc (SLRX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SLRX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 2 $5 $5 $5 $0.4 1150%
2022-03-14 2 $5 $4 $4.5 $0.4 1025%

Over the past 126 days, SLRX's average upside potential has been 811.14%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-08 2 5 5 5.0 0.825 506.06%
2022-03-14 2 5 4 4.5 0.370 1116.22%

SLRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SLRX as an investment opportunity.

  • Salarius Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 198.22% of all US stocks.
  • SLRX has a higher average analyst price target than 5% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, Salarius Pharmaceuticals Inc's number of analysts covering the stock is higher than 9.38% of them.
  • SLRX has a lower variance in analysts' estimates than 83.49% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Salarius Pharmaceuticals Inc are SLGL, SIGA, and SGTX.

What is the outlook for SLRX? Use POWR Ratings for clearer insight into price direction.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8866 seconds.